Primary Care Enhanced Services

The NHS Lincolnshire Integrated Care Board is in the process of awarding a contract under the Provider Selection Regime regulations for the provision of Primary Care Enhanced Services. The contract is set to cover services including phlebotomy, specialised drug monitoring, and safeguarding, among others. The services fall under the industry category for General Practitioner services, with the procurement located in the UKF3 region of the United Kingdom.

The current award stage signifies an intention to award notice, with the standstill period allowing providers to make representations until 15th September 2025. The contract, with an expected total value of £72,495, is scheduled to run from 1st April 2025 to 31st March 2026. This process follows a limited procurement method without prior publication of a call for competition, addressing the needs of existing services and providers.

This tender creates substantial opportunities for businesses involved in healthcare services, particularly those specialising in primary care enhancements and general practitioner services. Companies with existing contracts or those adept in providing innovative and quality healthcare solutions are well-suited to compete. The emphasis on integration, collaboration, and service sustainability may appeal to firms with capabilities in delivering comprehensive care packages that address health inequalities and ensure patient access.

SME [Small and Medium-sized Enterprises] healthcare providers, such as Caskgate Street Surgery, currently positioned as the supplier, exemplify the type of business that could benefit from this contract. These enterprises have the chance to expand their operations by leveraging existing services to meet the specified contract standards, thereby fostering long-term growth and development within the healthcare sector.